Location: Home > Pharma China Web Edition
  • search
  • go
  • Product/R&D News
  • 2/21/2025Hengrui Medicine Advances Dual GLP-1/GIP Agonist HRS9531 with First Ph...
  • 2/21/2025MediLink's YL217 Received FDA Clearance of IND Application
  • 2/20/2025Ascletis Reports Positive Interim Results from U.S. Phase Ib Study of ...
  • 2/18/2025NovoCodex's ARX788 Demonstrates Efficacy in HER2-Positive Advanced Bre...
  • 2/18/2025BioKin Initiates Phase III Trial in China for BL-B01D1 in NSCLC
  • 2/18/2025Huadong Medicine Announces Positive Results from HDM1005 Clinical Tria...
  • 2/17/2025Betta Pharma's Xcovery Initiates EMA Approval Process for Ensartinib i...
  • 2/17/2025BioNTech Initiates Phase 1/2 Trial for BNT327 and BNT323 Combination i...
  • 2/17/2025CSPC's SYS6005 ADC Enters Phase I Clinical Trials in China
  • 2/14/2025China Approves Novo Nordisk's Semaglutide Injection for New Indication
  • 2/14/2025NMPA Approves Sinocelltech's Finotonlimab for R/M HNSCC
  • 2/14/2025Trinomab's TNM002: A New Passive Immunization Agent for Emergency Teta...
  • 2/14/2025NMPA Approves SciClone's Vibativ for Drug-Resistant Gram-Positive Infe...
  • 2/13/2025Jiangsu Recbio's Novel HPV Vaccine Trial Approved in China
  • 2/12/2025Lion TCR's Liocyx-M004 Receives FDA IND Approval for Phase 2 Trial
  • 2/12/2025CSPC Granted NMPA Approval for Herpes Zoster mRNA Vaccine Clinical Tri...
  • 2/12/2025Merck Registers Kelun's Nectin-4 ADC MK-3120 and Initiates Phase 1 Tri...
  • 2/11/2025IVIEW Reports Positive Phase 1/2 Results for IVW-1001 Ophthalmic Eyeli...
  • 2/11/2025BioKin Pharma's HER2 ADC BL-M07D1 Advances to Phase III in China
  • 2/10/2025NMPA Approves Sinocelltech's Anti-PD-1 Antibody Finotonlimab
  • 2/10/2025Sunshine Lake Pharma's NS5A Inhibitor Netanasvir Phosphate Approved in...
  • 2/7/2025Toll Biotech Secures FDA and NMPA IND Approvals for TLR8 Modulator Tol...
  • 2/7/2025Henlius Biotech's Lung Cancer Drug Secures EU Approval
  • 2/5/2025MediLink's YL217 received FDA Clearance of IND Application
  • 2/2/2025FDA Approves Minwei Biotech's IND for MWN105
  • 2/2/2025BeiGene Launches Phase 1 Trial for CLDN6/CD3 BsAb BGB-B455 in Solid Tu...
  • 2/2/2025FDA Approves XellSmart's IND for iPSC-Derived Cell Therapy in Parkinso...
  • 1/28/2025Akeso's Gumokimab Advances Toward Approval in China for Plaque Psorias...
  • 1/28/2025Chinese Researchers Develop Promising Nanovaccine for Breast Cancer Tr...
  • 1/22/2025Innovent Advances PD-1/IL-2α-Bias Bispecific Antibody IBI363 into Pha...
  • Page:4/11 Total number of articles:316: [First][<<] [2] [3] [4] [5] [6] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group